These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 3784305)

  • 1. The absorption of dietary phosphorus and calcium in hemodialysis patients.
    Ramirez JA; Emmett M; White MG; Fathi N; Santa Ana CA; Morawski SG; Fordtran JS
    Kidney Int; 1986 Nov; 30(5):753-9. PubMed ID: 3784305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V; Torregrosa V
    Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of antacid administrations on aspirin absorption in patients with chronic renal failure on maintenance hemodialysis.
    Gaspari F; Viganò G; Locatelli M; Remuzzi G
    Am J Kidney Dis; 1988 Apr; 11(4):338-42. PubMed ID: 3354570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of small doses of aluminum-containing antacids on calcium and phosphorus metabolism.
    Spencer H; Kramer L; Norris C; Osis D
    Am J Clin Nutr; 1982 Jul; 36(1):32-40. PubMed ID: 7091034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aluminum accumulation during treatment with aluminum hydroxide and dialysis in children and young adults with chronic renal disease.
    Salusky IB; Foley J; Nelson P; Goodman WG
    N Engl J Med; 1991 Feb; 324(8):527-31. PubMed ID: 1992306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of aluminium hydroxide on calcium, phosphorus and aluminium balances, the serum parathyroid hormone concentration and the aluminium content of bone in patients with chronic renal failure.
    Clarkson EM; Luck VA; Hynson WV; Bailey RR; Eastwood JB; Woodhead JS; Clements VR; O'Riordan JL; De Wardener HE
    Clin Sci; 1972 Oct; 43(4):519-31. PubMed ID: 4653591
    [No Abstract]   [Full Text] [Related]  

  • 8. Calcium acetate, an effective phosphorus binder in patients with renal failure.
    Mai ML; Emmett M; Sheikh MS; Santa Ana CA; Schiller L; Fordtran JS
    Kidney Int; 1989 Oct; 36(4):690-5. PubMed ID: 2811066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of aluminium-hydroxide-containing antacids on the intestinal absorption of iron in patients on long-term dialysis].
    Blumberg A
    Schweiz Med Wochenschr; 1977 Jul; 107(30):1064-6. PubMed ID: 897649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controlled study of renal osteodystrophy in patients undergoing dialysis. Improved response to continuous ambulatory peritoneal dialysis compared with hemodialysis.
    Shusterman NH; Wasserstein AG; Morrison G; Audet P; Fallon MD; Kaplan F
    Am J Med; 1987 Jun; 82(6):1148-56. PubMed ID: 3605132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antacid therapy--changes in mineral metabolism.
    Herzog P; Holtermüller KH
    Scand J Gastroenterol Suppl; 1982; 75():56-62. PubMed ID: 6293043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alternative phosphate binders in dialysis patients: calcium carbonate.
    Slatopolsky E; Weerts C; Stokes T; Windus D; Delmez J
    Semin Nephrol; 1986 Dec; 6(4 Suppl 1):35-41. PubMed ID: 3602677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium balance in dialysis is best managed by adjusting dialysate calcium guided by kinetic modeling of the interrelationship between calcium intake, dose of vitamin D analogues and the dialysate calcium concentration.
    Gotch F; Levin NW; Kotanko P
    Blood Purif; 2010; 29(2):163-76. PubMed ID: 20093823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of paricalcitol and calcitriol on intestinal calcium absorption in hemodialysis patients.
    Lund RJ; Andress DL; Amdahl M; Williams LA; Heaney RP
    Am J Nephrol; 2010; 31(2):165-70. PubMed ID: 20016142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of vitamin D-dependent and vitamin D-independent mechanisms in absorption of food calcium.
    Sheikh MS; Ramirez A; Emmett M; Santa Ana C; Schiller LR; Fordtran JS
    J Clin Invest; 1988 Jan; 81(1):126-32. PubMed ID: 3335630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of antacids on the absorption of simultaneously ingested iron.
    O'Neil-Cutting MA; Crosby WH
    JAMA; 1986 Mar; 255(11):1468-70. PubMed ID: 3005669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of aluminum hydroxide and calcium carbonate antacids on the bioavailability of ciprofloxacin.
    Frost RW; Lasseter KC; Noe AJ; Shamblen EC; Lettieri JT
    Antimicrob Agents Chemother; 1992 Apr; 36(4):830-2. PubMed ID: 1503446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of CaCO3 alone and CaCO3 plus vitamin D3 in terms of calcium phosphorus product in chronic kidney diseases.
    Adhikary L; Acharya S; Acharya L
    J Nepal Health Res Counc; 2011 Apr; 9(1):67-70. PubMed ID: 22929717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of dietary phosphorus absorption by phosphorus binders. A theoretical, in vitro, and in vivo study.
    Sheikh MS; Maguire JA; Emmett M; Santa Ana CA; Nicar MJ; Schiller LR; Fordtran JS
    J Clin Invest; 1989 Jan; 83(1):66-73. PubMed ID: 2910921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium requirements in humans. Report of original data and a review.
    Spencer H; Kramer L; Lesniak M; De Bartolo M; Norris C; Osis D
    Clin Orthop Relat Res; 1984 Apr; (184):270-80. PubMed ID: 6368085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.